G. GÜNCAN Et Al. , "Formulation Design of the Oral Disintegrating Tablets Including Alfuzosin Hydrochloride with Risk Evaluation via Quality by Design," Acta Pharm. Sci. , vol.55, no.2, pp.57-76, 2017
GÜNCAN, G. Et Al. 2017. Formulation Design of the Oral Disintegrating Tablets Including Alfuzosin Hydrochloride with Risk Evaluation via Quality by Design. Acta Pharm. Sci. , vol.55, no.2 , 57-76.
GÜNCAN, G., ERGİNER, Y., Aksu, B., MESUT, B., & Yeğen, G., (2017). Formulation Design of the Oral Disintegrating Tablets Including Alfuzosin Hydrochloride with Risk Evaluation via Quality by Design. Acta Pharm. Sci. , vol.55, no.2, 57-76.
GÜNCAN, GÖZDE Et Al. "Formulation Design of the Oral Disintegrating Tablets Including Alfuzosin Hydrochloride with Risk Evaluation via Quality by Design," Acta Pharm. Sci. , vol.55, no.2, 57-76, 2017
GÜNCAN, GÖZDE Et Al. "Formulation Design of the Oral Disintegrating Tablets Including Alfuzosin Hydrochloride with Risk Evaluation via Quality by Design." Acta Pharm. Sci. , vol.55, no.2, pp.57-76, 2017
GÜNCAN, G. Et Al. (2017) . "Formulation Design of the Oral Disintegrating Tablets Including Alfuzosin Hydrochloride with Risk Evaluation via Quality by Design." Acta Pharm. Sci. , vol.55, no.2, pp.57-76.
@article{article, author={GÖZDE GÜNCAN Et Al. }, title={Formulation Design of the Oral Disintegrating Tablets Including Alfuzosin Hydrochloride with Risk Evaluation via Quality by Design}, journal={Acta Pharm. Sci.}, year=2017, pages={57-76} }